What is the official website of Clinical Trials & Drug Development Courses - University of Geneva ?

The official website of Clinical Trials & Drug Development Courses - University of Geneva is https://www.unige.ch/formcont/en/courses/clinical-trials.

Has Clinical Trials & Drug Development Courses - University of Geneva been affected by any supply chain cyber incidents ?

According to Rankiteo, Clinical Trials & Drug Development Courses - University of Geneva has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Clinical Trials & Drug Development Courses - University of Geneva have PCI DSS certification ?

According to Rankiteo, Clinical Trials & Drug Development Courses - University of Geneva does not currently maintain PCI DSS compliance.

Does Clinical Trials & Drug Development Courses - University of Geneva have ISO 27001 certification ?

According to Rankiteo,Clinical Trials & Drug Development Courses - University of Geneva is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

How many LinkedIn followers does Clinical Trials & Drug Development Courses - University of Geneva have ?

Clinical Trials & Drug Development Courses - University of Geneva's official LinkedIn profile has approximately 757 followers.

What is the NAICS classification code for Clinical Trials & Drug Development Courses - University of Geneva ?

Clinical Trials & Drug Development Courses - University of Geneva is classified under the NAICS code 6113, which corresponds to Colleges, Universities, and Professional Schools.

Does Clinical Trials & Drug Development Courses - University of Geneva have a Crunchbase profile ?

No, Clinical Trials & Drug Development Courses - University of Geneva does not have a profile on Crunchbase.

Does Clinical Trials & Drug Development Courses - University of Geneva have a LinkedIn profile ?

Yes, Clinical Trials & Drug Development Courses - University of Geneva maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/das-mas-clinical-unige.

How many peer or competitor companies does Clinical Trials & Drug Development Courses - University of Geneva have ?

Clinical Trials & Drug Development Courses - University of Geneva has an estimated 17,407 peer or competitor companies worldwide.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

CTDDCUG

Boost Score +25 with badge (5 left)

770

/1000

Fair

795

/1000

Fair

Clinical Trials & Drug Development Courses - University of Geneva Vendor Cyber Rating & Cyber Score

unige.ch

Add Your Compliance Badge

Good Clinical Practice implementation and quality processes provide a theoretical and practical understanding of how these principles are shaping each step of a Clinical Trial, including study design, trial management, and conduct.

CTDDCUG

Clinical Trials & Drug Development Courses - University of Geneva CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

CTDDCUG Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for CTDDCUG

Incidents vs Higher Education Industry Avg (This Year)

No incidents recorded for Clinical Trials & Drug Development Courses - University of Geneva in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Clinical Trials & Drug Development Courses - University of Geneva in 2026.

Incident Types CTDDCUG vs Higher Education Industry Avg (This Year)

No incidents recorded for Clinical Trials & Drug Development Courses - University of Geneva in 2026.

Incident History - CTDDCUG (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Clinical Trials & Drug Development Courses - University of Geneva Subsidiaries

CTDDCUG

Higher Education

Website: https://www.unige.ch/formcont/en/courses/clinical-trials

Company Size: 1,001-5,000 employees

Université de GenèveForschungsdienstleistungen

Geneva School of Economics and Management - UNIGEForschungsdienstleistungen

Faculty of Science | University of GenevaHochschulen und Universitäten

Faculté de droit - UNIGEHochschulen und Universitäten

Faculté de psychologie et des sciences de l'éducation - UNIGEHochschulen und Universitäten

Centre de carrière – UNIGEPersonalwesen

Faculty of Medicine - UNIGEHigher Education

Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO)- University of GenevaHochschulen und Universitäten

Formation des adultes – Université de GenèveHochschulen und Universitäten

Centre en philanthropie (GCP)- UNIGEBildungsverwaltungsprogramme

Geneva Summer Schools - UNIGEHochschulen und Universitäten

Centre interfacultaire en droits de l’enfant (CIDE) - UNIGEBildungsmanagement

Pôle SEA – Soutien à l’enseignement – UNIGEHochschulen und Universitäten

Gouvernance de l’Environnement et Développement TerritorialBildungsverwaltungsprogramme

Service égalité & diversité - UNIGEHochschulen und Universitäten

Institut des sciences de l'environnement (ISE) - UNIGEHochschulen und Universitäten

Programme Horizon académiqueEducation Administration Programs

Centre Maurice Chalumeau en sciences des sexualitésBildungsverwaltungsprogramme

Life Sciences PhD School GenevaHochschulen und Universitäten

Department of Earth Sciences - UNIGEBildungsmanagement

Swiss Center for Affective Sciences (CISA) - UNIGE)Bildungsverwaltungsprogramme

Section de physique - UNIGEHochschulen und Universitäten

InZone - UNIGEHochschulen und Universitäten

Right to Truth, Truth(s) through RightsForschungsdienstleistungen

Science Innovation Hub - UNIGEBildungsverwaltungsprogramme

Scienscope - UNIGEHigher Education

Centre Universitaire d’Informatique (CUI) - UNIGEHigher Education

Service de soutien à la recherche - UNIGEBildungsverwaltungsprogramme

Section of mathematics - UNIGEHochschulen und Universitäten

Centre Jean PiagetHigher Education

TECFA - UNIGEResearch Services

Institute of Global Health - UNIGEPublic Health

Geneva Centre for Inflammation Research - UNIGEForschungsdienstleistungen

Master of Science in Wealth Management - UNIGEHigher Education

Institut Universitaire de Formation pour l'Enseignement (IUFE)Hochschulen und Universitäten

Global Studies Institute (GSI) – Université de GenèveHigher Education

Centre du Droit de l’Art / Art-Law CentreHochschulen und Universitäten

Psychologie sociale – UNIGEResearch Services

Section de biologie – UNIGEForschungsdienstleistungen

Genève Évasions Mathématiques (G·EM) - UNIGEHochschulen und Universitäten

Master in European and International Governance - MEIG ProgrammeBildungsverwaltungsprogramme

Formation continue - Université de GenèveHigher Education

Loading…

Clinical Trials & Drug Development Courses - University of Geneva Similar Companies

Virginia Tech

vt.edu

Dedicated to its motto, Ut Prosim (That I May Serve), Virginia Tech takes a hands-on, engaging approach to education, preparing scholars to be leaders in their fields and communities. As the commonwealth’s most comprehensive university and its leading research institution, Virginia Tech offers 215 undergraduate and graduate degree programs to 31,000 students and manages a research portfolio of $450 million. The university fulfills its land-grant mission of transforming knowledge to practice through technological leadership and by fueling economic growth and job creation locally, regionally, and across Virginia.

The University of Georgia

uga.edu

The University of Georgia, a land-grant and sea-grant university with state-wide commitments and responsibilities, is the state's flagship institution of higher education. It is also the state's oldest, most comprehensive and most diversified institution of higher education. Its motto, "to teach, to serve and to inquire into the nature of things," reflects the university's integral and unique role in the conservation and enhancement of the state's and nation's intellectual, cultural and environmental heritage.

The California State University

calstate.edu

The  California State University is the largest system of four-year higher education in the country, with 22 campuses, 56,000 faculty and staff and more than 450,000 students. Created in 1960, the mission of the CSU is to provide high-quality, affordable education to meet the ever-changing needs of California. With its commitment to quality, opportunity, and student success, the CSU is renowned for superb teaching, innovative research and for producing job-ready graduates. The CSU powers California and the nation, sending nearly 127,000 career-ready graduates into the workforce each year. In fact, one in every 20 Americans holding a college degree earned it at the CSU and our alumni are 4 million strong.

University of Alberta

ualberta.ca

The University of Alberta is one of Canada’s top teaching and research universities, with an international reputation for excellence across the humanities, sciences, creative arts, business, engineering, and health sciences. Home to more than 39,000 students and 15,000 faculty and staff, the university has an annual budget of $1.7 billion and attracts nearly $450 million in sponsored research revenue. The U of A offers close to 400 rigorous undergraduate, graduate, and professional programs in 18 faculties on five campuses. The university has more than 250,000 alumni worldwide. The university and its people remain dedicated to the promise made in 1908 by founding president Henry Marshall Tory that knowledge shall be used for “uplifting the whole people."

University of Wisconsin-Madison

wisc.edu

In achievement and prestige, the University of Wisconsin–Madison has long been recognized as one of America's great universities. A public, land-grant institution, UW–Madison offers a complete spectrum of liberal arts studies, professional programs and student activities. Spanning 936 acres along the southern shore of Lake Mendota, the campus is located in the city of Madison.

Washington University in St. Louis

washu.edu

Washington University in St. Louis, a medium-sized, independent university, is dedicated to challenging its faculty and students alike to seek new knowledge and greater understanding of an ever-changing, multicultural world. The university has played an integral role in the history and continuing growth of St. Louis and benefits in turn from the wide array of social, cultural and recreational opportunities offered by the metropolitan area to its more than 2.8 million residents. The mission of Washington University in St. Louis is the promotion of learning — learning by students and by faculty. Teaching, the transmission of knowledge, is central to our mission, as is research, the creation of new knowledge.

The University of North Carolina at Chapel Hill

unc.edu

Carolina’s vibrant people and programs attest to the University’s long-standing place among leaders in higher education since it was chartered in 1789 and opened its doors for students in 1795 as the nation’s first public university. Situated in the beautiful college town of Chapel Hill, N.C., UNC has earned a reputation as one of the best universities in the world. Carolina prides itself on a strong, diverse student body, academic opportunities not found anywhere else, and a value unmatched by any public university in the nation. UNC-Chapel Hill's LinkedIn comments guidelines: Thank you for liking the LinkedIn page of the University of North Carolina at Chapel Hill. This page highlights information about the people and programs at Carolina. Consistent with UNC-Chapel Hill’s Policy on Prohibited Discrimination, Harassment and Related Misconduct, and the North Carolina Campus Free Speech Act, we encourage your comments and opinions as they relate to our posts. This page is actively monitored for relevance. Carolina reserves the right to remove any comments that are not related to the particular post, make unsupported accusations, contain ad-hominem attacks, use obscene language or images, are blatant spam, contain advertisements, or contain inappropriate personal information or sensitive information. Repeated violation of these guidelines or behavior that substantially disrupts the maintenance of this page could result in a user being blocked from the page. Thanks for keeping the page enjoyable for everyone. Go Tar Heels!

Tecnológico de Monterrey

tec.mx

The Tecnológico de Monterrey is a private university system with 33 campuses in 26 cities in Mexico, which serves more than 96,000 students in its high school, undergraduate and graduate programs. It also has liaison offices in 12 countries. Through the promotion of research, generation of knowledge transfer models and technology, it promotes the building of a knowledge-based economy to support the economic, political and social development of the country's regions.

Uppsala University

uu.se

Uppsala University strives to bring new perspectives to the basic questions of science as well as knowledge contributing to sustainable development and human health. We offer 39 different master programmes covering over 60 different specialisations. In Uppsala you walk in the gardens of Linnaeus, follow in the footsteps of Nobel laureates, and at the same time meet today’s – and tomorrow’s – smartest teachers and researchers. Uppsala University. Quality, knowledge and creativity. Since 1477. Please address questions on official matters to [email protected]

Loading…

NEWS

Clinical Trials & Drug Development Courses - University of Geneva CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

January 21, 2026 04:07 AM

DeepMind spinout Isomorphic Labs eyes first drug trials in 2026

Isomorphic Labs, an AI-driven drug discovery company backed by Google, expects to begin its first clinical trials by the end of 2026,...

Read Article

January 21, 2026 03:17 AM

Corvus Pharmaceuticals Launches $150 Million Public Offering to Fund Clinical Trials

Public Offering Announcement**: Corvus Pharmaceuticals has launched a $150 million public offering, consisting of common shares and...

Read Article

January 20, 2026 11:37 PM

Adjuvant CDK4/6 Inhibitors Gain Ground as Oral SERDs Emerge to Tackle Endocrine Resistance in Early HR+ Breast Cancer

Recent readouts from the phase 3 monarchE (NCT03155997) and NATALEE (NCT03701334) trials are reinforcing adjuvant CDK4/6 inhibition as a...

Read Article

January 20, 2026 10:34 PM

Myotonic Dystrophy Clinical Trial Pipeline Expands as 20+

Press release - ABNewswire - Myotonic Dystrophy Clinical Trial Pipeline Expands as 20+ Companies Driving Innovation in the Therapeutics...

Read Article

January 20, 2026 10:32 PM

Fibromyalgia Clinical Trial Pipeline Appears Robust With 8+ Key

Press release - ABNewswire - Fibromyalgia Clinical Trial Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Domain...

Read Article

January 20, 2026 10:30 PM

Hemophagocytic Lymphohistiocytosis Clinical Trial Pipeline

Press release - ABNewswire - Hemophagocytic Lymphohistiocytosis Clinical Trial Pipeline Shows Potential with Active Contributions from 5+...

Read Article

January 20, 2026 10:10 PM

Seltorexant for MDD Does Not Lead to Weight Gain in Patients with Obesity

In a 26-week trial, adjunctive seltorexant, versus quetiapine, for major depressive disorder (MDD) prevented weight gain in patients with...

Read Article

January 20, 2026 09:52 PM

Episode 265: Redesigning Clinical Trials Through Technology with Patrick McCarthy of Validcare

Hosts Heather and Lauren sit down with Patrick McCarthy, CEO of Validcare, to discuss how technology is reshaping the future of clinical...

Read Article

January 20, 2026 09:28 PM

FDA proposes guidance on endpoints for multiple myeloma therapeutics accelerated approval trials

The US Food and Drug Administration (FDA) has outlined its thinking on how to design and execute clinical trials in which sponsors can use...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-93740

SUMMARY

A vulnerability was identified in Totolink A3002MU Hh-B20211125.1046. Affected is the function formWlEncrypt of the file /boafrm/formWlEncrypt. The manipulation of the argument submit-url leads to buffer overflow. It is possible to initiate the attack remotely. The exploit is publicly available and might be used.

Published

Date2026-09-18

Updated

Date2026-09-18

RISK INFORMATION (Score: 10)

cvss2

Base Score: 10.0

Complexity: LOW

AV:N/AC:L/Au:N/C:C/I:C/A:C

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.9

REFERENCES

CVE-2026-93739

SUMMARY

A vulnerability was determined in Totolink A3002MU Hh-B20211125.1046. This impacts the function formWlAc of the file /boafrm/formWlAc. Executing a manipulation of the argument submit-url can lead to buffer overflow. The attack may be performed from remote. The exploit has been publicly disclosed and may be utilized.

Published

Date2026-09-18

Updated

Date2026-09-18

RISK INFORMATION (Score: 9.9)

cvss2

Base Score: 9.0

Complexity: LOW

AV:N/AC:L/Au:S/C:C/I:C/A:C

cvss3

Base Score: 9.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.1

REFERENCES

CVE-2026-75885

SUMMARY

A flaw was found in the OpenShift console. Unauthenticated access to the `/api/devfile/` and `/api/devfile/samples/` endpoints allows a remote attacker to send crafted devfile payloads. This can lead to Server-Side Request Forgery (SSRF), where the console pod makes requests to internal services and reflects partial responses to the attacker. Additionally, by sending repeated large requests without a specified content length, an attacker can cause unbounded memory growth, leading to a Denial of Service (DoS).

Published

Date2026-09-18

Updated

Date2026-09-18

RISK INFORMATION (Score: 9.3)

cvss3

Base Score: 9.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:N/A:L

Impact Score

4.7

Exploitability

3.9

REFERENCES

CVE-2026-93894

SUMMARY

In Vinyl Cache before 9.0,2, workspace buffer overflow vulnerability was found in the .upper() and .lower() string type methods of VCL. This can be used as a remote denial of service (DoS) vector to make the child process segfault or assert, and then restart. Effectively exploiting this vulnerability requires prior knowledge about the VCL in use and the ability to craft a request that contains a string that is long enough to fill the remaining workspace at the call site while staying under the different request size limits (http_req_size, http_req_hdr_len, etc.).

Published

Date2026-09-18

Updated

Date2026-09-18

RISK INFORMATION (Score: )

cvss4

Base Score: 2.3

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:P/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:N/R:A/V:D/RE:L/U:Clear

Impact Score

Exploitability

REFERENCES

https://vinyl-cache.org/security/VSV00020.html

CVE-2026-93738

SUMMARY

A vulnerability was found in Totolink A3002MU Hh-B20211125.1046. This affects the function formSchedule of the file /boafrm/formSchedule. Performing a manipulation of the argument webpage results in buffer overflow. The attack is possible to be carried out remotely. The exploit has been made public and could be used.

Published

Date2026-09-18

Updated

Date2026-09-18

RISK INFORMATION (Score: 9.9)

cvss2

Base Score: 9.0

Complexity: LOW

AV:N/AC:L/Au:S/C:C/I:C/A:C

cvss3

Base Score: 9.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.1

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Clinical Trials & Drug Development Courses - University of Geneva Vendor Cyber Rating & Cyber Score

CTDDCUG A.I CyberSecurity Scoring

Clinical Trials & Drug Development Courses - University of Geneva CyberSecurity News & History

CTDDCUG Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for CTDDCUG

Incidents vs Higher Education Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types CTDDCUG vs Higher Education Industry Avg (This Year)

Incident History - CTDDCUG (X = Date, Y = Severity)

Clinical Trials & Drug Development Courses - University of Geneva Subsidiaries

CTDDCUG

Clinical Trials & Drug Development Courses - University of Geneva Similar Companies

Virginia Tech

The University of Georgia

The California State University

University of Alberta

University of Wisconsin-Madison

Washington University in St. Louis

The University of North Carolina at Chapel Hill

Tecnológico de Monterrey

Uppsala University

Clinical Trials & Drug Development Courses - University of Geneva CyberSecurity News

DeepMind spinout Isomorphic Labs eyes first drug trials in 2026

Corvus Pharmaceuticals Launches $150 Million Public Offering to Fund Clinical Trials

Adjuvant CDK4/6 Inhibitors Gain Ground as Oral SERDs Emerge to Tackle Endocrine Resistance in Early HR+ Breast Cancer

Myotonic Dystrophy Clinical Trial Pipeline Expands as 20+

Fibromyalgia Clinical Trial Pipeline Appears Robust With 8+ Key

Hemophagocytic Lymphohistiocytosis Clinical Trial Pipeline

Seltorexant for MDD Does Not Lead to Weight Gain in Patients with Obesity

Episode 265: Redesigning Clinical Trials Through Technology with Patrick McCarthy of Validcare

FDA proposes guidance on endpoints for multiple myeloma therapeutics accelerated approval trials

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Clinical Trials & Drug Development Courses - University of Geneva CyberSecurity News & History

CTDDCUG Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for CTDDCUG

Incidents vs Higher Education Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types CTDDCUG vs Higher Education Industry Avg (This Year)

Incident History - CTDDCUG (X = Date, Y = Severity)

Clinical Trials & Drug Development Courses - University of Geneva Subsidiaries

CTDDCUG

Clinical Trials & Drug Development Courses - University of Geneva Similar Companies

Virginia Tech

The University of Georgia

The California State University

University of Alberta

University of Wisconsin-Madison

Washington University in St. Louis

The University of North Carolina at Chapel Hill

Tecnológico de Monterrey

Uppsala University

Clinical Trials & Drug Development Courses - University of Geneva CyberSecurity News

DeepMind spinout Isomorphic Labs eyes first drug trials in 2026

Corvus Pharmaceuticals Launches $150 Million Public Offering to Fund Clinical Trials

Adjuvant CDK4/6 Inhibitors Gain Ground as Oral SERDs Emerge to Tackle Endocrine Resistance in Early HR+ Breast Cancer

Myotonic Dystrophy Clinical Trial Pipeline Expands as 20+

Fibromyalgia Clinical Trial Pipeline Appears Robust With 8+ Key

Hemophagocytic Lymphohistiocytosis Clinical Trial Pipeline

Seltorexant for MDD Does Not Lead to Weight Gain in Patients with Obesity

Episode 265: Redesigning Clinical Trials Through Technology with Patrick McCarthy of Validcare

FDA proposes guidance on endpoints for multiple myeloma therapeutics accelerated approval trials

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo